Peptide finder

What are you trying to change?

Pick as many as you like. The number on each one is how many people it has been measured in across the whole archive. So you can see where the evidence is before you choose.

1. 01ErythropoietinBiologicStrong. At least two finished studies in people, and at least 1,000 people who took it. 3 completed trials, 4,641 people given it.6 reported

   4,038 people1 study

   • This drug did not extend life or save kidneys, and it doubled the risk of stroke. 4,038 people with type 2 diabetes, kidney disease and anaemia got darbepoetin alfa or a dummy shot, with rescue treatment if counts dropped too low. Death and heart events came out the same. Kidney failure came out the same. Strokes hit...

     New England Journal of Medicine, 2009 · 4,038 people

2. 02BromantaneSmall moleculeModerate. At least one finished study in people, and at least 100 people who took it. 3 completed trials, 728 people given it.6 reported

   728 people1 study

   • The largest study of bromantane had nothing to compare itself against. 728 patients at 28 Russian clinics took it for four weeks. Nine in ten were rated improved by their doctor. Side effects were rare and almost nobody quit. Here is the problem. Everybody got the drug, everybody knew it, and the score was a doctor's...

     Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova, 2010 · 728 people

3. 03ElamipretidePeptideModerate. At least one finished study in people, and at least 100 people who took it. 5 completed trials, 487 people given it.6 reported

   218 people1 study1 found nothing

   • found nothingIt was tested properly, at full scale, and it failed. 218 people with an inherited muscle disease caused by faulty mitochondria got elamipretide or a dummy injection, and nobody involved knew which. Both of the things the trial was built to settle came out flat. Walking distance in six minutes was 3.2 metres worse on...

     Neurology, 2023 · 218 people

4. 04OxaloacetateSupplementModerate. At least one finished study in people, and at least 100 people who took it. 2 completed trials, 112 people given it.4 reported

   82 people1 study

   • Oxaloacetate cut fatigue more than the comparison group in people with ME and chronic fatigue syndrome. 82 people took 2,000 mg a day for three months, assigned by chance, and nobody involved knew who got what. Fatigue fell by more than a quarter in the treated group against roughly a tenth in the controls. About 40.5...

     Frontiers in Neurology, 2024 · 82 people

5. 05MifepristoneSmall moleculeModerate. At least one finished study in people, and at least 100 people who took it. 2 completed trials, 320 people given it.4 reported

   50 people1 study

   • In Cushing's syndrome, where cortisol is the problem, blocking its receptor with mifepristone improved blood sugar, blood pressure and weight over six months. 50 adults took part, and there was no dummy pill group. Tiredness, nausea, headache and low potassium were common. This is the approved use, not a study of...

     The Journal of Clinical Endocrinology and Metabolism, 2012 · 50 people

6. 06MelittinPeptideModerate. At least one finished study in people, and at least 100 people who took it. 5 completed trials, 658 people given it.4 reported

   26 people1 study

   • Bee sting therapy failed on every measure it was tested on. Twenty six people with relapsing multiple sclerosis were stung up to twenty times a session, three times a week, for six months. Brain scans showed no fewer new lesions. Relapses, disability, fatigue and quality of life were all unchanged. Nobody was...

     Neurology, 2005 · 26 people

7. 07Melanotan IIPeptideStrong. At least two finished studies in people, and at least 1,000 people who took it. 5 completed trials, 1,310 people given it.9 reported

   3 people1 study

   • The first look at this compound in people was tiny, and the side effect it turned up became the reason people buy it. Three male volunteers took shots under the skin for two weeks. Their skin darkened, which was the point. Most doses made them feel sick, and the highest left them drowsy and tired. They also got...

     Life Sciences, 1996 · 3 people

8. 08TestosteroneHormoneModerate. At least one finished study in people, and at least 100 people who took it. 1 completed trial, 5,246 people given it.10 reported

   number of people not given1 study1 found nothing

   • found nothingTestosterone helped older men with sex and did much less for everything else. It raised their levels to what a man in his twenties or thirties would have. Sex drive, sexual activity and erections all clearly got better. Energy did not get better at all. Walking distance only improved when three studies were lumped...

     New England Journal of Medicine, 2016 · number of people not given

9. 09RetatrutidePeptideStrong. At least two finished studies in people, and at least 1,000 people who took it. 5 completed trials, 1,345 people given it.8 reported

   number of people not given0 studies
10. 10Thymosin Beta-4PeptideStrong. At least two finished studies in people, and at least 1,000 people who took it. 5 completed trials, 1,382 people given it.9 reported

    number of people not given0 studies
11. 11Vitamin B12SupplementLimited. People have taken it in a published study, but fewer than 100 of them. 2 completed trials, none stating how many people.4 reported

    number of people not given0 studies
12. 12Urolithin ASupplementLimited. People have taken it in a published study, but fewer than 100 of them. 2 completed trials, none stating how many people.4 reported

    number of people not given0 studies
13. 13DasatinibSmall moleculeLimited. People have taken it in a published study, but fewer than 100 of them. 3 completed trials, 74 people given it.3 reported

    number of people not given0 studies
14. 14EnobosarmSmall moleculeModerate. At least one finished study in people, and at least 100 people who took it. 1 completed trial, 159 people given it.5 reported

    number of people not given0 studies
15. 15CardarineSmall moleculePreliminary. Studied in people, but no published study has had people take it. 1 registered with no result.7 reported

    number of people not given0 studies
16. 16NattokinaseBiologicStrong. At least two finished studies in people, and at least 1,000 people who took it. 9 completed trials, 1,795 people given it.6 reported

    number of people not given0 studies
17. 17DHEAHormoneModerate. At least one finished study in people, and at least 100 people who took it. 3 completed trials, 267 people given it.5 reported

    number of people not given0 studies
18. 18LamivudineSmall moleculeLimited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, none stating how many people.3 reported

    number of people not given0 studies
19. 19PQQSupplementModerate. At least one finished study in people, and at least 100 people who took it. 3 completed trials, 116 people given it.5 reported

    number of people not given0 studies
20. 20NAD+ / B ComplexBlendLimited. People have taken it in a published study, but fewer than 100 of them. 5 completed trials, 34 people given it.8 reported

    number of people not given0 studies
21. 21Semaglutide with B12BlendLimited. People have taken it in a published study, but fewer than 100 of them. 2 completed trials, none stating how many people.7 reported

    number of people not given0 studies
22. 22Thymosin alpha-1 with KPV and LL-37BlendStrong. At least two finished studies in people, and at least 1,000 people who took it. 3 completed trials, 1,140 people given it.6 reported

    number of people not given0 studies
23. 23CoQ10SupplementModerate. At least one finished study in people, and at least 100 people who took it. 2 completed trials, 162 people given it.4 reported

    number of people not given0 studies
24. 24RusfertidePeptideModerate. At least one finished study in people, and at least 100 people who took it. 5 completed trials, 166 people given it.

    number of people not given0 studies